Detection

Detection refers to whether a given analytical method can identify a substance or its metabolites in a biological sample — and whether it can do so at concentrations actually present in that sample. The concept encompasses several interrelated variables: the choice of biological matrix (blood, urine, hair, oral fluid), the type of assay being used, and the detection window — the period after consumption during which a substance or its breakdown products remain above a method's limit of detection.

A result is always relative to what a test was designed to find. Routine immunoassay panels check for a fixed list of compounds at thresholds calibrated for those compounds. Most novel and less commonly used substances simply do not appear on standard panels; a negative screen says nothing about them.

How it works · its role

Detection typically occurs in two stages. An initial screen — usually an immunoassay, a technique that uses antibodies to flag target molecules — runs quickly across a fixed panel of substance classes. If the screen is positive, a confirmatory test using mass spectrometry (most commonly gas chromatography–mass spectrometry or liquid chromatography–tandem mass spectrometry) identifies the exact compound and measures its concentration.

The detection window depends on how rapidly the body clears a substance, which metabolites are produced and how long they persist, the matrix being tested, and individual variation in metabolism. Urine generally offers the longest windows because the kidneys concentrate metabolites over time. Hair can preserve evidence of exposure for months but cannot resolve precise timing. Blood and oral fluid reflect more recent use and correspond more closely to active pharmacological effects.

Metabolites — the breakdown products the liver produces — are often the primary target rather than the parent drug, because they tend to be more abundant, more stable in biological fluids, or more structurally specific to a given substance.

Relevance to substances & effects

Detection windows can diverge sharply from the duration of psychoactive effects, and that gap is practically significant. Cannabis is the clearest example: its primary psychoactive compound clears the blood within hours, but its major urinary metabolite remains detectable for days in occasional users and weeks in heavy users — long after any subjective effect has passed.

For most substances in this index — particularly novel psychoactive substance, research chemicals, and less commonly tested compounds — standard immunoassay panels will return a negative result regardless of exposure. A targeted laboratory method, ordered specifically for that compound class, is required to find them.

This distinction matters for harm reduction. A person undergoing occupational, forensic, or clinical testing should understand what a given panel does and does not cover. A clinician reviewing a negative result should understand that not found means not found by this method — not not present. Detection is a technical parameter of an assay, not a direct measure of drug use or its absence.